Sifalimumab

Tax included
Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research.
MedChemExpress 
HY-P99219

Data sheet

Size
Multiple sizes
Reactivity
IFNAR
Application
COVID-19-immunoregulation
CAS
1006877-41-3